Elevara Medicines

Private

AltrinchamHealthcare & Life Scienceshttps://www.elevara.com/

Last Round

Series A

Oct 22, 2025

Total Funding Raised

$140M

Company Overview

Elevara Medicines is a clinical-stage biotechnology company developing novel therapeutics to treat rheumatoid arthritis and other chronic inflammatory conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyrheumatoid arthritisCDK4/6 inhibitorclinical-stage biotechfibroblast-like synoviocytesdrug developmentchronic inflammatory diseaseclinical trialssmall-molecule therapybiotech startuporal therapeuticdrug discoveryadd-on therapypharma pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elevara Medicines Comps

Public and private peers based on sector, stage, and business model.

Elevara Medicines comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Elevara Medicines Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Oct 22, 2025
Series A	Sep 1, 2025
Seed	Mar 1, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Emma Tinsley

CEO & Founder

Founding Team

Elevara Medicines Investors

Notable investors and investment history

Elevara Medicines investors
Investor	Rounds
Forbion	Series A
Monograph Capital	Series A, Seed
Sofinnova Partners	Series A

View all Investors

Elevara Medicines Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Elevara Medicines Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Elevara Medicines's valuation, stock price, and market status.

Firmographic Details

HeadquartersAltrincham

Employee Range13

Year Founded2025

Last FundingOct 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.